Economic Atlas
Companies/Abbott Laboratories
Company profile

Abbott Laboratories

NYSE: ABT · Healthcare · Medical - Devices
PublicHQ Abbott Park, ILCIK 0000001800Reports USD
#18 of 1,422 Healthcare companies by revenue49th-percentile growth
EA Score
87A
Revenue TTM
$45.1B
Rev growth YoY (TTM)
+6.6%
Net income (FY)
$6.5B
Employees
114,000
as of 2026-08-04
Market cap
$185.4B
as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$44.3B$44.3B2025
Net income$6.5B$6.5B2025
Operating income$8.1B$8.1B2025
Total assets$86.7B$86.7B2025
Equity$52.1B$52.1B2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Medical Devices48%
Diagnostic Products20%
Nutritional Products19%
Established Pharmaceutical Products12%
By geography
UNITED STATES40%
Non-US37%
D [E]6%
C [N]4%
C [H]4%
I [N]4%
The read

What is Abbott Laboratories’s revenue?

Abbott Laboratories booked $44.3B in FY2025 revenue, growing 5.7% year over year — about the middle of the pack among Healthcare companies we track, at a 14.7% net margin.

Peers · Healthcare
Bristol-Myers Squibb Company85AMolina Healthcare, Inc.83B+Thermo Fisher Scientific Inc.86AAmgen Inc.88AMedtronic plc84B+Gilead Sciences, Inc.87A
Key facts
CEORobert Ford
SectorHealthcare
IndustryMedical - Devices
HeadquartersAbbott Park, IL
ExchangeNYSE: ABT
Employees114,000
IPO date1980-03-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.